Pharma Intelligence is part of the Informa Intelligence Division of Informa PLC
This is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Senior Editor
{A1EF0A44-49EE-467F-964C-F748991F5552}
+2 year(s) experience
HBW Insight
By David Ridley 07 Aug 2019
Japan's new Rx-to-OTC switch procedure has exacerbated a "switch lag" compared with developed countries, says Japan Self-Medication Industry senior adviser Toshi Tominaga in an exclusive interview with HBW Insight. Tominaga proposes improvements such as self-care education for consumers and drug usage advice included by firms in switch applications to help balance the risk-benefit decisions of expert judges.
Topic Policy and regulation
HBW Insight
By David Ridley 05 Jul 2019
The UK's cannabidiol market, which according to the Cannabis Trades Association is the largest in Europe, awaits clarification on the legal status of CBD-containing food supplements. Meanwhile, major retailers like Walgreen Boots Alliance are stepping into the space with branded products.
HBW Insight
By David Ridley 07 Mar 2019
A new position paper by Food Supplements Europe calculates the potential savings that targeted supplementation with omega-3, calcium, phytosterols and vitamins D and B9 could bring for cash-strapped European governments.
